findmyKOL

Venkatesh Ravi, MD

Basic profile

Saint Francis Hospital

ORCIDNPI
RegionTulsa, OK · South CentralSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Venkatesh Ravi is a Cardiology physician affiliated with Saint Francis Hospital. OpenAlex indexes 54 publications with 1,186 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
54publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,186citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
29companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6151 S Yale Ave Ste 1-304
Tulsa, OK 741361907

Telephone

918-494-5300

Provider last certified this registry record 17 Jun 2021.

View the NPPES registry record

Industry payments

29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    69.3%
    Beta blocker35.2%
    Metoprolol Succinate57%Metoprolol Tartrate25%Carvedilol14%Nadolol4%
    Part D<11 patients
    Antiarrhythmic21.7%
    Flecainide Acetate52%Amiodarone Hcl40%Multaq8%
    Part D<11 patients

    + 5 more classes in this area

  • Blood & clotting

    27.8%
    Factor Xa inhibitor27.8%
    Eliquis91%Xarelto9%
    Part D<11 patients
  • Metabolism & gastrointestinal

    1.7%
    Potassium supplement1.7%
    Potassium Chloride100%
    Part D11 patients
Where care is delivered (Part B)58.7% facility · 41.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”